Willemijn J. van Rijt

Prediction of disease severity in multiple acyl‐CoA dehydrogenase deficiency: A retrospective and laboratory cohort study

Willemijn J. van Rijt, Sacha Ferdinandusse, Panagiotis Giannopoulos et al. · Journal of Inherited Metabolic Disease · 2019 · 28 citations · Full text

Life Sciences, Biochemistry, Lipid Biochemistry +16

Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders

Karen van Eunen, Catharina M.L. Volker‐Touw, Albert Gerding et al. · BMC Biology · 2016 · 23 citations · Full text

Life Sciences, Biochemistry, Cellular Metabolism +16

Enantiomer‐specific pharmacokinetics of D,L‐3‐hydroxybutyrate: Implications for the treatment of multiple <scp>acyl‐CoA</scp> dehydrogenase deficiency

Willemijn J. van Rijt, Johan L.K. Van Hove, Frédéric M. Vaz et al. · Journal of Inherited Metabolic Disease · 2021 · 22 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +6

Favorable Outcome After Physiologic Dose of Sodium-<scp>d,l</scp>-3-Hydroxybutyrate in Severe MADD

Willemijn J. van Rijt, M. Rebecca Heiner‐Fokkema, Gideon J. du Marchie Sarvaas et al. · PEDIATRICS · 2014 · 19 citations · Full text

Medicine, Cardiology, Pharmacology +13

Instability of Acylcarnitines in Stored Dried Blood Spots: The Impact on Retrospective Analysis of Biomarkers for Inborn Errors of Metabolism

Willemijn J. van Rijt, Peter C. J. I. Schielen, Yasemin Özer et al. · International Journal of Neonatal Screening · 2020 · 18 citations · Full text

Natural Sciences, Biochemistry, Analytical Chemistry +16